About Brian Overstreet
Form D filings for Arbital Health from 2023 to 2024 list Brian Overstreet as director, CEO and CFO.
Brian Overstreet first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Brian Overstreet in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Brian Overstreet works with at each company, as listed on that company's latest Form D.
Arbital Health, Inc. · Form D/A, Aug 27, 2024